期刊文献+

钙离子拮抗剂和血管紧张素转换酶抑制剂对高血压患者动脉僵硬度影响的荟萃分析 被引量:1

Meta-analysis of the effects of calcium channel blockers and angiotensin-converting-enzyme inhibitor on arterial stiffness in patients with hypertension
下载PDF
导出
摘要 目的系统评价钙离子拮抗剂(calcium channel blockers,CCBs)和血管紧张素转换酶抑制剂(angiotensin-converting-enzyme inhibitor,ACEI)对原发性高血压(高血压)患者血管功能作用的差异。方法按循证医学的要求,制定相应的纳入、排除标准及其检索策略。通过PubMed、EMBASE、Ovid EBM Reviews、中国期刊全文数据库、中文科技期刊全文数据库、万方数据库,检索相关的临床对照研究,计算机检索时间从各数据库建库至2012年1月;同时辅助其他检索,纳入CCBs和ACEI治疗高血压患者的随机对照试验(randomized controlled trials,RCT)。两名评价者独立评价纳入研究的质量,并用统一的表格提取资料,采用RevMan5.0软件进行统计分析。比较CCBs和ACEI对高血压患者脉搏波传导速度、收缩压、舒张压、脉压等指标的影响。结果共纳入4篇RCT,共计226例患者。文献异质性检验显示数据存在异质性(Q=54.80,P<0.001)。荟萃分析结果显示,ACEI在改善动脉僵硬度方面优于CCBs,差异有统计学意义(标准差=135.01,95%CI:59.87~210.16;Z=3.52,P=0.0004,P<0.05);但在降低收缩压(标准差=-4.73,95%CI:-9.35~-0.12,P<0.04)和舒张压(标准差=-10.42,95%CI:-19.16~-1.69,P<0.02)方面较CCBs弱;在降低脉压(标准差=-6.12,95%CI:-2.3~14.55,P<0.15)方面与CCBs相比,差异无统计学意义。结论ACEI在改善高血压患者动脉僵硬度方面优于CCBs,该作用与其降压作用无关。 Objectives To evaluate the effects of calcium channel blockers (CCBs) and angiotensin-converting-enzyme inhibitor (ACEI) on the vascular function in patients with hypertension. Methods Based on the principles of evidencebased medicine, corresponding inclusion and exclusion criteria, along with search strategies were developed. We searched PubMed, EMBASE, Ovid EBM Reviews, Chinese Biomedical Literature Database, Chinese Scientific Journal Full-text Database and Chinese Journal Full-text Database up to January 2012 to identify randomized controlled trials (RCTs), comparing the effects of CCBs with those of ACEI on arterial stiffness in patients with hypertension. Two reviewers independently evaluated the quality of the included studies, extracted data with a unified form and analyzed the data by Coehrane Collaboration's RevMan 5.0 software. The comparisons between the effects of CCBs and ACEI on pulse wave velocity (PWV), systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP) in patients with hypertension were performed. Results Four RCTs involving 226 patients were included. Literature heterogeneity analysis revealed that literature heterogeneity existed (Q=54.80, P〈O.001 ). Meta-analysis indicated that ACEI was better in improving arterial stiffness than CCBs (standard deviation=135.01, 95%CI: 59.87-210.16; Z=3.52,P=O.OOO4,P〈 0.05); while the effects of ACEI on lowering SBP (standard deviation=-4.73,95%CI:-9.35 - -0.12,P〈0.04) and DBP (standard deviation=- 10.42, 95%CI : - 19.16 - - 1.69, P〈0.02) were not so good as those of CCBs. There was no significant difference in lowering pulse pressure between CCBs and ACEI (standard deviation=-6.12, 95%CI:-2.3- 14.55 ,P〈0.15). Conclusions Effects of ACEI on reducing arterial stiffness is better than CCBs, which is not related to their antihypertensive function.
出处 《岭南心血管病杂志》 2012年第6期586-590,638,共6页 South China Journal of Cardiovascular Diseases
基金 国家自然科学基金资助项目(项目编号:30800462 30900659)
关键词 高血压 钙离子拮抗剂 血管紧张素转换酶抑制剂 荟萃分析 hypertension calcium channel blockers angiotensin-converting-enzyme inhibitor meta-analysis
  • 相关文献

参考文献17

  • 1LAURENT S. Evidence for benefits of perindopril in hypertension and its complications [ J ]. Am J Hypertens, 2005, 18(9 pt 2) : 155s-162s.
  • 2MAKENZIE I S, MCENIERY C M, DHAKAM Z, et al. Comparision of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension[J]. Hypertension, 2009, 54(2): 409-413.
  • 3NAKAMURA T, SATO E, FUJIWARA N, et al. Comparative effects of benidipine and amlodipine on proteinuria, urinary 8- OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease [J ]. Am J Med Sci, 2010, 339(2) : 157-163.
  • 4MALLAREDDY M, PARIKH C R, PEIXOTO A J. Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: systematic review and meta-analysis [J]. J Clin Hypertens, 2006, 8(6): 398-403.
  • 5KARALLIEDDE J, SMITH A, DEANGELIS L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering [J]. Hypertension, 2008, 51(6): 1617-1623.
  • 6ICHIHARA A, KANESHIRO Y, SAKODA M, et al. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker [ J ]. J Cardiovasc Pharmacol, 2007, 49 ( 3 ) : 161 - 166.
  • 7HASSAGER C, THYGESEN K, GRANDE P, et al. Different effects of calcium antagonist and beta-blocker therapy on left- ventricular diastolic function in ischemic heart disease [J]. Cardi- ology, 2001, 96(2): 65-71.
  • 8MORIMOTO S, MAKI K, AOTA Y, et al. Beneficial effects of combination therapy with angiotensin U receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function [ J ]. Hypertens Res, 2008, 31 ( 8 ) : 1603-1610.
  • 9BLACHER J, ASMAR R, DJANE S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients[J]. Hypertension, 1999, 33(5): 1111-1117.
  • 10MANCIA G, DE BACKER G, DOMINICZAK A, et al. 2007 Guidelines for the Management of Arterial Hypertension:The Task Force for tbe Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the EuropeanSociety of Cardiology (ESC) [J].Hypertension, 2007, 25 (6) : 1105-1187.

二级参考文献8

  • 1亓鹏.VALUE研究与高血压治疗的现代观点[J].解放军保健医学杂志,2005,7(1):55-56. 被引量:3
  • 2Franklin SS,Khan SA,Wong ND,et al. Is pulse pressure useful in predicting risk for coronary heart disease:the Framingham heart study [J]. Cireulation, 1999,100:354-360.
  • 3Blacher J, Staessen JA, Girend X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients[J]. Arch Intern Med,2000,160:1085-1089.
  • 4Laurent S,Boutouyrie P,Asmar R,et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients [J ]. Hypertension,2001,37 : 1236-1241.
  • 5Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients [J]. Hypertension, 1999,33 : 1111-1117.
  • 62007 Guidelines for the management of arterial hypertension the task forces for the management of arterial hypertension of the european society of hypertension(ESH)and of the European society of cardiology ( ESC ) [ J ]. Hypertension, 2007,25 : 1105-1187.
  • 7Munakata M, Nagasaki A, Nunokawa T, et al. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients[J ]. Am J Hypertension,2004,17:1050-1055.
  • 8Siragy HM, Gasparo MD, Carey RM. Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats [J]. Hypertension, 2000,35 : 1074-1077.

同被引文献12

  • 1Dolan E, Thijs L, Li Y, et al. Ambulatory arterial stiffness index as a predietor of eardiovaseular mortality in the Dublin Outeome Study [ J ]. Hypertension, 2006, 47 ( 3 ) : 365-370.
  • 2Aznaouridis K, Vlachopoulos C, Protogerou A, et al. Ambulatory systolic-diastolic pressure regression index as a predictor of clinical events: a meta-analysis of longitudinal studies [J]. Stroke, 2012, 43: 733-739.
  • 3Kollias A, Stergiou GS, Dolan E, et al. Ambulatory arterial stiffness index: a systematic review and meta-analysis [ J ]. Atherosclerosis, 2012, 224: 291-301.
  • 4Li ZY, Xu TY, Zhang SL, etal. Telemetric ambulatory arterial stiffness index, a predictor of cardio-cerebro-vascular mortality, is associated with aortic stiffness-determining factors[J]. CNS Neurosci Ther, 2013, 19: 667-674.
  • 5Celik T, Fici F. The association between inflammation and left ventricular diastolic dysfunction in patients with hypertension: another piece of the puzzle [ J 1Nutr Metab Cardiovasc Dis, 2013, 23(6): e26-627.
  • 6Wang C, Zhang J, Li CC, et al. The ambulatory arterial stiffness index and target-organ damage in Chinese patients with chronic kidney disease [ J ]. BMC Nephml, 2013, 14 : 257.
  • 7Bastos J, Filipa S, Joana S, et al. The prognostic value of ambulator arterial stiffness index as a predictor of cardiovascular events in resistant hypertensive patients [ J ] .9 J Hypertens, 2015, 33: e74.
  • 8Lee E, Emoto M, Teramura M, et al. The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes [ J ]. J Atheroscler THromb, 2009, 16(6) : 332-391.
  • 9O'Rourke MF. Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance [ J ]. J Am Coil Cardiol, 2001, 38(3): 803-805.
  • 10刘杰,薛浩,张威,朱航,石亚军,付振虹.高血压患者肱踝动脉脉搏波传导速度与左心室肥厚的相关性[J].解放军医学院学报,2013,34(7):687-689. 被引量:9

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部